Selected article for: "different vaccine efficacy and vaccine efficacy"

Author: Vineet D. Menachery; Lisa E. Gralinski; Hugh D. Mitchell; Kenneth H. Dinnon; Sarah R. Leist; Boyd L. Yount; Eileen T. McAnarney; Rachel L. Graham; Katrina M. Waters; Ralph S. Baric
Title: Combination attenuation offers strategy for live-attenuated coronavirus vaccines
  • Document date: 2018_4_28
  • ID: 3t75dbb7_1
    Snippet: Emergent coronaviruses remain a significant threat to global public health and rapid response 23 vaccine platforms are needed to stem future outbreaks. However, failure of many previous CoV 24 vaccine formulations has clearly highlighted the need to test efficacy under different conditions 25 and especially in vulnerable populations like the aged and immune-compromised. This study 26 illustrates that despite success in young models, the NSP16 mut.....
    Document: Emergent coronaviruses remain a significant threat to global public health and rapid response 23 vaccine platforms are needed to stem future outbreaks. However, failure of many previous CoV 24 vaccine formulations has clearly highlighted the need to test efficacy under different conditions 25 and especially in vulnerable populations like the aged and immune-compromised. This study 26 illustrates that despite success in young models, the NSP16 mutant carries too much risk for 27 pathogenesis and reversion in vulnerable models to be used as a stand-alone vaccine strategy.

    Search related documents:
    Co phrase search for related documents
    • different condition and vulnerable population: 1
    • efficacy test and global rapid public health response: 1, 2
    • efficacy test and public health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • efficacy test and rapid public health: 1, 2
    • efficacy test and rapid public health response: 1, 2
    • efficacy test and significant threat: 1, 2
    • efficacy test and stand vaccine strategy: 1, 2
    • efficacy test and vaccine strategy: 1, 2
    • efficacy test and vulnerable population: 1
    • future outbreak and public health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • future outbreak and rapid public health: 1
    • future outbreak and rapid public health response: 1
    • future outbreak and significant threat: 1
    • future outbreak and vaccine platform: 1
    • future outbreak and vaccine strategy: 1, 2
    • future outbreak and vulnerable population: 1, 2
    • global rapid public health response and public health: 1, 2, 3, 4
    • global rapid public health response and rapid public health: 1, 2, 3, 4
    • global rapid public health response and rapid public health response: 1, 2, 3, 4